Recent Overview of Boussard & Gavaudan Holding Limited's Net Asset Value
Boussard & Gavaudan Holding Limited NAV Update
Ordinary Shares
The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company.
Estimated NAV
As of the close of business, the estimated Net Asset Value (NAV) for the shares is as follows:
Euro Shares
Estimated NAV: €28.7027
Estimated Month-To-Date (MTD) Return: 0.20%
Estimated Year-To-Date (YTD) Return: 4.19%
Estimated Inception-To-Date (ITD) Return: 187.03%
Sterling Shares
Estimated NAV: £25.7075
Estimated Month-To-Date (MTD) Return: 0.22%
Estimated Year-To-Date (YTD) Return: 4.63%
Estimated Inception-To-Date (ITD) Return: 157.07%
NAV and returns are calculated net of management and performance fees.
Market Information
The current market close details for the shares are as follows:
Euro Shares
Market Close: €27.00
Premium/Discount to Estimated NAV: -5.93%
Sterling Shares
Market Close: GBX 2,200.00
Premium/Discount to Estimated NAV: -14.42%
Transactions in Own Securities
The company has made the following transactions in its own securities:
Ordinary Shares:
Euro Shares
Number of Shares: N/A
Average Price: N/A
Sterling Shares
Number of Shares: N/A
Average Price: N/A
Liquidity Enhancement Agreement
Incorporating a liquidity enhancement agreement:
Euro Shares
Number of Shares: N/A
Average Price: N/A
Sterling Shares
Number of Shares: N/A
Average Price: N/A
BGHL Capital
The details related to BGHL Ordinary Shares are as follows:
Euro Shares
Shares Outstanding: 12,299,516
Held in Treasury: N/A
Shares Issued: 12,299,516
Sterling Shares
Shares Outstanding: 123,090
Held in Treasury: N/A
Shares Issued: 123,090
Estimated BG Fund NAV
Estimated NAV for BG Fund Class B and GBP A Shares are:
Class B Euro Shares
Estimated NAV: €258.9339
Class GBP A Shares
Estimated NAV: £137.7305
The Class B Euro Shares are not subject to investment manager fees, as the Investment Manager receives management fees and performance fees for its role as Investment Manager of BGHL.
For further information, please contact:
Boussard & Gavaudan Investment Management, LLP. Emmanuel Gavaudan +44 (0) 20 3751 5389 Email: info@bgam-uk.com
The Company is established as a closed-ended investment company domiciled in Guernsey and has received the necessary approval from relevant authorities. The shares are listed on Euronext Amsterdam and also on the Official List of the UK Listing Authority.
Investors should be aware of the risks associated with investments. Past performance does not guarantee future results, and investment performance may fluctuate, leading to potential loss of capital. It is advised to seek expert financial advice when considering investment decisions.
Frequently Asked Questions
What is the estimated NAV for Euro Shares of BGHL?
The estimated NAV for Euro Shares is €28.7027.
What is the estimated YTD return for Sterling Shares?
The estimated Year-To-Date (YTD) return for Sterling Shares is 4.63%.
How many Euro Shares are outstanding for BGHL?
Currently, there are 12,299,516 Euro Shares outstanding for BGHL.
What is the market close price for Euro Shares?
The market close price for Euro Shares is €27.00.
Who should I contact for further information regarding BGHL?
For further information, contact Emmanuel Gavaudan at Boussard & Gavaudan Investment Management, LLP or via email at info@bgam-uk.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Investors of Spire Global: Your Rights and How to Act Now
- Understanding the Recent Allegations Against PDD Holdings Inc.
- Saba Capital Income & Opportunities Fund II Shares Distribution Insights
- Pratt & Whitney Secures Major Contract for F135 Engine Upgrades
- Exploring the Growth of 3D Printing in Affordable Satellite Systems
- Major Milestone for RTX's Pratt & Whitney with New Contract
- Cohen & Steers Funds Announce Upcoming Distributions for Shareholders
- Sona Jones Joins YMCA of Metropolitan Chicago to Enhance Wellbeing
- 23andMe's Wojcicki Shifts Focus Away from Takeover Offers
- Cohen & Steers Funds Announce Upcoming Monthly Distributions
Recent Articles
- Crossject Set to Showcase Innovations at Global Conference
- Sampo plc Announces Share Buybacks on August 21
- GN Store Nord Q2 2024 Interim Report: Steady Growth and Profitability
- Belships ASA Reports Impressive Q2 2024 Financial Results
- Aegon Announces First Half Year 2024 Financial Results
- Kinepolis Faces Visitor Drop Amid Promising Film Line-Up
- DNO ASA Announces Ex-Dividend Trading for Shareholders
- Biotalys Half-Year Financial Results 2024 Overview
- Aegon Announces Shawn C.D. Johnson as New CEO of Aegon AM
- Belships ASA Announces NOK 0.55 Dividend Per Share
- Belships ASA Announces Cash Dividend Distribution Details
- CN Initiates Lockout Amidst Negotiation Challenges
- Nutricosmetics Market Insights and Future Growth Potential
- Fancy Yarn Market Set to Reach $8.67 Billion by 2033
- Quantum Dot Market Insights and Future Growth Analysis
- Nokia Fuels TM's Optical Network for Enhanced Connectivity
- Xanadu Mines Expands Kharmagtai Copper-Gold Resource
- Yotta Acquisition Corporation and DRIVEiT Merger Announcement
- Firan Technology Group's NCIB Renewal Announcement
- Colon: The Original Doge Memecoin and Its Legacy
- Future Growth of Thin Film Drug Manufacturing Market
- Enact Holdings Update on Capital Position and PMIERs
- Insights on NMI Holdings' Capital Position and PMIERs
- DMG Blockchain Solutions Inc. Announces Q3 2024 Financial Results
- Ottawa Bancorp, Inc. Declares Quarterly Cash Dividend
- Draganfly Secures $2 Million in Direct Offering
- Remembering Dr. Alastair Carruthers: A Dermatology Pioneer
- Global Aircraft Hangar Market Growth Insights
- C.F. Crozier & Associates Expands Leadership Team
- Giga Metals Completes Significant Financing for Growth
- CSX Corp Secures Labor Agreements with Wage Hikes
- Northrop Grumman Announces Quarterly Dividend Declaration
- Orca Energy Group Declares Quarterly Cash Dividend
- Pixalate Q2 2024 Mobile Device Market Share Revealed
- Exploring the Growth of Self-Healing Concrete Market
- Aurora Spine Announces Strong Q2 2024 Financial Performance
- Quorum Information Technologies Inc. Reports Strong Q2 2024 Results
- Premier Health Posts Q3 2024 Financial Results
- Element Fleet Management Leadership Changes Announced
- Cytek Biosciences Receives ISO 13485 Certification
- STMicroelectronics Releases 2024 Semi Annual Financial Accounts
- Skyline Bankshares, Inc. Confirms Dividend Announcement
- First Capital, Inc. Declares Quarterly Dividend Increase
- SOS Ltd. Faces NYSE Compliance Challenge for ADS Price
- Guardion Health Sciences Announces $5.00 Dividend Per Share
- Global Medical Device CRO Market to Reach $15.54 Billion
- Globus Medical Unveils Innovative ADIRA™ XLIF™ Plate System
- SigmaTron International Faces Nasdaq Compliance Challenge
- Ultragenyx Grants Stock Units to New Executives
- Dycom Industries, Inc. Engages in Key Investor Conferences